The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies
James F Donohue,1 Ayca Ozol-Godfrey,2 Thomas Goodin,2 Shahin Sanjar2 1Department of Pulmonary Diseases and Critical Care Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USACorrespondence: James F DonohueDepartment of P...
Main Authors: | Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/the-effect-of-baseline-rescue-medication-use-on-efficacy-and-safety-of-peer-reviewed-article-COPD |
Similar Items
-
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]
by: Donohue JF, et al.
Published: (2020-05-01) -
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
by: Ohar JA, et al.
Published: (2020-05-01) -
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]
by: Ohar JA, et al.
Published: (2021-05-01) -
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
by: Tashkin DP, et al.
Published: (2021-04-01) -
Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4
by: Ohar J, et al.
Published: (2018-12-01)